Des mdicaments comme le smaglutide (Wegovy) et le tirzpatide (Zepbound) ont montr une efficacit suprieure aux anciens mdicaments de perte de poids, avec des patients perdant jusqu 20 % de leur poids corporel
Davies TG, Field LM, Usherwood PN, Williamson MS
On Monday, the Food and Drug Administration approved baricitinib, a once-a-day pill developed by the drugmaker Eli Lilly to treat alopecia areata, an autoimmune disease that triggers sudden hair loss
125250 mcg per session 35 times per week Duration: 812 weeks Because these doses closely match levels used in dermatology research, they typically offer steady, visible improvement
Yeah, the big cheesy one, extra cheese, of course
The FDA prescribing information warns about the risk of acute kidney injury in this setting, and patients may require intravenous fluids or temporary medication discontinuation